Characteristics

Cases N=154(%)

Wild type GG N=86(%)

Heterozygous GT N=64(%)

Homo mutant TT N=4(%)

P-Value

Age of Diagnosis
21-30
31-40
41-50
51-60
61-70


16(10%)
38(25%)
50(32%)
38(25%)
12(8%)


6(38%)
20(53%)
32(64%)
22(58%)
6(50%)


10(62%)
16(42%)
18(36%)
14(37%)
6(50%)


0(0%)
2(5%)
0(0%)
2(5%)
0(0%)


0.16
0.35
0.005
0.06
1.00

Body mass index(BMI) status
Normal weight >18.50 to <24.99
Overweight >25 to <29.99
Obese >30.00

  
30(19%)
40(26%)
84(55%)


17(57%)
22(55%)
47(57%)


13(43%)
18(45%)
33(33%)


0(0%)
0(0%)
4(10%)


0.14
0.37
0.03

Age at Menarche
11-12
13-14
15-16


52(34%)
84(54%)
18(12%)


34(65%)
48(57%)
4(22%)


16(31%)
36(43%)
12(67%)


2(4%)
0(0%)
2(11%)


0.0005
0.06
0.01

Menopausal Status
Post Menopausal
Pre Menopausal


80(52%)
74(48%)


48(60%)
38(51%)


30(38%)
34(46%)


2(2%)
2(3%)


0.004
0.51

Estrogen Receptor status
ER+ /PR+
ER+/PR-
ER-/PR+
ER-/PR-


48(31%)
10(7%)
6(4%)
90(58%)


28(58%)
8(80%)
4(67%)
46(51%)


20(42%)
2(20%)
2(33%)
40(44%)


0(0%)
0(0%)
0(0%)
4(5%)


0.10
0.01
0.25
0.37

Her2 status
Her2+
Her2-


135(88%)
19(12%)


78(58%)
8(42%)


54(40%)
10(53%)


3(2%)
1(5%)


0.003
0.50

Chemotherapy
5FU,Adriamycin,Endoxane
Hormonal therapy
RD
No Data


108(70%)
11(7%)
28(18%)
7(4%)


62(57%)
6(55%)
16(57%)
2(29%)


42(39%)
5(45%)
12(43%)
5(71%)


4(4%)
0(0%)
0(0%)
0(0%)


0.006
0.67
0.28
0.12

Table 6: Correlation of breast cancer patients demographic factors and ADIPOQ +45G/T genotype frequencies.